SF1

Across TCGA pan-cancer cohorts, SF1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SF1 data layer compared with 22 for mass-spec protein and 9 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher SF1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated SF1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and COAD show a favorable association.

LUAD, COAD, and UCEC are the cancer types where SF1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Quartile	All	0.976	0.698	.002	43	view →
COAD	DFS	Median	III,IV	1.000	0.846	.049	6	view →
UCEC	DFS	Median	All	1.000	0.936	.023	4	view →
LSCC	OS	Median	II,III,IV	0.884	0.625	.022	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

SF1–LUAD (OS)

Open the LUAD breakdown →